Insider Selling: Mineralys Therapeutics, Inc. (NASDAQ:MLYS) CFO Sells $141,346.98 in Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) CFO Adam Scott Levy sold 10,757 shares of the business’s stock in a transaction dated Thursday, July 11th. The shares were sold at an average price of $13.14, for a total transaction of $141,346.98. Following the completion of the sale, the chief financial officer now directly owns […]

Leave a Reply

Your email address will not be published.

Previous post Resilience and optimism: SME barometer shows rising business confidence despite economic hurdles
Next post Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) Short Interest Up 58.4% in June